Medovex Overview
- Founded
-
2013
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
HCYTD
- Investments
-
3
- Share Price
-
$19.95
- (As of Monday Closing)
Medovex General Information
Description
H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
PINX
Primary Office
- 3060 Royal Boulevard South
- Suite 150
- Alpharetta, GA 30022
- United States
+1 (404) 000-0000
Medovex Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.95 | $19.95 | $10.00 - $289.00 | $5.09M | 255K | 59.24 | -$34.12 |
Medovex Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 11,231 | 12,164 | 29 | 15,160 |
| Revenue | 1,615 | 1,612 | 2,151 | 8,347 |
| EBITDA | (7,033) | (4,607) | (4,915) | (28,674) |
| Net Income | (7,283) | (4,799) | (6,459) | (29,808) |
| Total Assets | 701 | 321 | 2,204 | 3,271 |
| Total Debt | 3,556 | 3,618 | 1,173 | 2,894 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Medovex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medovex Patents
Medovex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3407810-A1 | Surgical tools for spinal facet therapy to alleviate pain | Pending | 29-Jan-2016 | 000000000 | |
| US-10595919-B2 | Surgical tools with positional components | Active | 12-Dec-2014 | 000000000 | 000 |
| US-20180310975-A1 | Surgical tools with positional components | Granted | 12-Dec-2014 | 00000000000 | 00 |
| EP-3190997-B8 | Surgical tools with positional components | Active | 12-Dec-2014 | 00000000000 | |
| EP-3190997-A4 | Surgical tools with positional components | Granted | 12-Dec-2014 | A61B17/8861 | 0 |
Medovex Executive Team (7)
Medovex Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 000000000 | Self | Board Member | 000 0000 |
| 0000000 0000000000 | Medovex | Board Member | 000 0000 |
| 0000000 00000 | Medovex | Chief Executive Officer & Chairman | 000 0000 |
Medovex Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Medovex Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Medovex Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 11-Jan-2022 | 0000000000 | Other Devices and Supplies | 0000000 0 | |
| 000000000000 | 14-Jan-2019 | 000000000 | Buildings and Property | 0000000 0 | |
| Streamline (Healthcare) | 26-Mar-2015 | Merger/Acquisition | 00.00 | Other Healthcare Technology Systems | 0000000 0 |